Global Albumin in Pharmaceuticals Market USD 300 Million by 2020

Global Albumin in Pharmaceuticals Market USD 300 Million by 2020

Albumin is a concentrate of plasma proteins from blood and it works by increasing plasma volume or serum albumin levels. Albumin is used in treating a variety of conditions, including shock due to blood loss in the body, burns, low protein levels due to surgery or liver failure, and as an additional medicine in bypass surgery.

According to a market research report Albumin Market 2016-2020, published by iHealthcareAnalyst, Inc., the global albumin in pharmaceuticals market is estimated to reach USD 300 Million in 2020, expanding at a CAGR of 2.4% from 2016 to 2020.

Visit the Albumin in Pharmaceuticals Market 2016-2020 report at https://www.ihealthcareanalyst.com/report/albumin-market/

The global albumin in pharmaceuticals market segmentation is based on type (human serum albumin, bovine serum albumin, recombinant albumin), and its applications (drug formulation and drug delivery, vaccines, components of media). The global albumin market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020).

The global albumin in pharmaceuticals market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Albumin Type
1.1 Human Serum Albumin(HSA)
1.2 Bovine Serum Albumin(BSA)
1.3 Recombinant Albumin(rAlbumin)

2. Application
2.1 Drug Formulation and Drug Delivery
2.2 Vaccines
2.3 Components of Media

3. Geography (Region, Country)
3.1 North America (U.S., Canada)
3.2 Latin America (Brazil, Mexico, Rest of LA)
3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4 Asia Pacific (Japan, China, India, Rest of APAC)
3.5 Rest of the World

4. Company Profiles
4.1 CSL Behring LLC
4.2 HiMedia Laboratories
4.3 InVitria (Ventria Bioscience)
4.4 MedxBio Pte.Ltd.
4.5 Mitsubishi Tanabe Pharma
4.6 Novozymes A/S
4.7 Octapharma AG
4.8 RayBiotech, Inc.
4.9 Sigma-Aldrich Corporation
4.10 Thermo Fisher Scientific, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2016-12-21T21:34:49+00:00 Categories: Press Releases|